Compare Alcon AG (ALC) vs Tilray Brands Inc (TLRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alcon AG vs Tilray Brands Inc — how do they compare? Alcon AG trades at $72.96 (market cap $36.44B), while Tilray Brands Inc trades at $4.77 (market cap $649.42M). The key difference: Alcon AG is far larger — about 56.1× Tilray Brands Inc's market cap, and Alcon AG pays a 0.48% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.
| ALC | TLRY | |
|---|---|---|
Market Cap | $36.44B | $649.42M |
Sector | Health | Health |
52-Week High | $90.12 | $21.00 |
52-Week Low | $62.02 | $3.88 |
Enterprise Value | $40.28B | $816.55M |
Dividend Yield | 0.48% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →
